Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human neuregulin injection in chronic systolic heart failure
CTR20130356Phase 3Suspended
- Sponsor
- Zensun
- Start
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of neucardin in heart failure with reduced ejection fraction (HFrEF), sponsored by Zensun. Started Mar 2014; status: suspended.
02
Drugs
neucardin
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on CTR20130356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130356.